The startup develops automated microbioreactors that leverage microtechnology to enhance precision in biochemical processes. This technology improves scalability and reproducibility in bioprocessing, leading to more efficient production of biological materials.
Funding
$6.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional cell culture methods often lack the precision needed for efficient bioprocessing, leading to inconsistent results and scalability challenges in cell line development, protein production, and drug screening. Existing systems may not adequately control critical environmental parameters or provide sufficient throughput for comprehensive analysis.
Solution
CYTENA BPS develops automated microbioreactor systems that leverage microtechnology to enhance precision, scalability, and reproducibility in bioprocessing. Their solutions, including the S.NEST, C.NEST, and C.BIRD platforms, enable parallel cultivations in 24- or 96-well plates, bringing production bioreactor environments to a microscale. These systems facilitate earlier identification of high-producing and stable clones, reduce passaging steps, and streamline scaling-up processes. The S.NEST platform further integrates real-time dissolved oxygen (DO) and pH sensing directly into the wells, providing continuous metabolic monitoring without the need for scale-up or endpoint-only snapshots.
Target Audience
The primary customers are scientists and researchers in biopharmaceutical companies and academic institutions involved in cell line development, protein production, virus production, cell therapy, stem cell research, single-cell expansion, and drug screening.
Features
- Automated microbioreactors for cell line development, high-yield protein production, virus production, and drug screening
- S.NEST platform with real-time dissolved oxygen (DO) and pH sensing in 24- and 96-well formats
- C.NEST system with patented mixing technology for nutrient homogenization and oxygen transfer
- C.BIRD microbioreactor for single-cell expansion and clone selection
- Programmable mixing capabilities to replicate fluid dynamics of scalable systems
- Enhanced control over environmental parameters for consistent cell growth
- High-throughput capabilities for efficient analysis and optimization of cell cultures
- Streamlined workflows for cell line development and biopharmaceutical production